Figure 1 Worldwide distribution of disease burden attributable to environmental risks in 2012 Figure 1 | Worldwide distribution of disease burden attributable.

Slides:



Advertisements
Similar presentations
Using nutrition to modulate health effects of environmental pollutants Michelle A. Mendez Dept of Nutrition UNC-Chapel Hill.
Advertisements

WASH Cluster – Emergency Training D D1 1 WASH Related Diseases Session 1 The Environmental Burden of Disease.
Melody Sherwood, Peter A McCullough  The Lancet Global Health 
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Life expectancy at birth in all countries included
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 4 Interplay between acute kidney injury (AKI),
Figure 6 Effects of adiponectin on podocyte function
Figure 5 Inter-relationships between sleep apnoea, CKD and brain injury Figure 5 | Inter-relationships between sleep apnoea, CKD and brain injury. In chronic.
Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.
Figure 6 Differences in glycaemic control with the study drug
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Physiological changes in the renal system in pregnancy
Figure 2 Proinflammatory mechanisms in CKD
Nat. Rev. Nephrol. doi: /nrneph
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Global rates of sodium, fruit, and vegetable intake
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Bad-metal behaviour and electron correlations
Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.
Figure 7 The efficacy of phosphate-binder therapy
Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)
Figure 5 Risk factor control in the intensive treatment group
Figure 2 Physical activity and obesity levels by WHO-designated region and sex Figure 2 | Physical activity and obesity levels by WHO-designated region.
Figure 2 The network of chronic diseases and their mutual influences
Figure 2 Three distinct mechanisms of activation of
Figure 1 The burden of chronic kidney disease (CKD)
Figure 3 Societal costs for the care of patients with chronic kidney disease in the UK Figure 3 | Societal costs for the care of patients with chronic.
Figure 2 Podocyte dysfunction is a common feature of renal injury
Figure 1 Sequential impact of diabetes platforms, genetic backgrounds and accelerators on albuminuria and kidney pathology in mouse models of diabetic.
Figure 1 Acute kidney injury and chronic kidney disease
Figure 4 The gut–kidney axis, inflammation and cardiovascular disease in CKD Figure 4 | The gut–kidney axis, inflammation and cardiovascular disease in.
Figure 2 The continuum of acute kidney injury (AKI),
Figure 4 Model of changes in the serum levels
Figure 5 Potential roles of phosphate and fibroblast growth factor 23 (FGF-23) in the development of cardiovascular disease in patients with chronic kidney.
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Cardiovascular risk and disease across the life-course
Nat. Rev. Nephrol. doi: /nrneph
Melody Sherwood, Peter A McCullough  The Lancet Global Health 
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Stroke-related deaths and DALYs by country development status
Figure 5 The nephron-centric model of renal transplant fibrosis based on the injury-related molecular events observed in biopsy samples in the first year.
Figure 6 Combining population-wide and high-risk strategies
Figure 3 Serum phosphate level is associated with
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Regulation of TGF-β1/Smad signalling by microRNAs (miRs) in tissue fibrosis Figure 3 | Regulation of TGF-β1/Smad signalling by microRNAs (miRs)
Figure 1 The relationship between health fitness and pathogen load
Volume 70, Issue 11, Pages (December 2006)
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Patient, facility, health-care system and industry factors
Figure 3 Preventive strategies for CSA-AKI
Figure 4 The relationship between the time-dependent changes in the expression of immunoglobulin, mast cell, acute kidney injury (AKI), and fibrillar collagen.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 4 Intracellular distribution and
Figure 1 Overall worldwide prevalence ranges for SLE
Anaesthesia-related maternal mortality in low-income and middle-income countries: a systematic review and meta-analysis  Soha Sobhy, MBBS, Prof Javier.
Nat. Rev. Nephrol. doi: /nrneph
Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries Mattias Öberg, PhD, Maritta S Jaakkola,
Figure 1 Relationships between genetic variants, quantitative traits and diseases Figure 1 | Relationships between genetic variants, quantitative traits.
Chapter 77 Cervical Cancer: Burden of Disease
Presentation transcript:

Figure 1 Worldwide distribution of disease burden attributable to environmental risks in 2012 Figure 1 | Worldwide distribution of disease burden attributable to environmental risks in 2012. As a proportion of total disease burden, the burden of disease attributable to environmental risks is higher in low-income and middle-income countries than in high-income countries. Reprinted from World Health Organization, Prüss-Ustün, A., Wolf, J., Corvalán, C., Bos, R. & Neira, M. Preventing disease through healthy environments: a global assessment of the burden of disease from environmental risks, copyright (2016), REF. 7. Reprinted from World Health Organization, Prüss-Ustün, A., Wolf, J., Corvalán, C., Bos, R. & Neira, M. Preventing disease through healthy environments: a global assessment of the burden of disease from environmental risks, copyright (2016). Xu, X. et al. (2018) Environmental pollution and kidney diseases Nat. Rev. Nephrol. doi:10.1038/nrneph.2018.11